Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major...
Professor David Burgner is a practising paediatric infectious diseases physician, leads the Inflammatory Origins Group and co-leads the LifeCourse longitudinal observational cohorts initiative at Murdoch Children’s Research Institute. He holds major national and international clinical / research positions including leadership roles in ASID, ESPID, WSPID and is an AAHMS fellow.
Professor Burgner is an international authority on understanding the susceptibility and consequences to childhood infection and inflammation, particularly in relation to the development of cardiometabolic disease risk. He is an internationally recognised clinical and scientific leader in Kawasaki disease and has made major scientific, clinical and policy contributions to the Australian response to the COVID-19 pandemic, particularly the hyperinflammatory post-infectious syndrome (known as PIMS-TS or MIS-C) in children.
Top Publications
Pham, C, Vryer, R, O'Hely, M, Mansell, T, Burgner, D, Collier, F, Symeonides, C, Tang, MLK, Vuillermin, P, Gray, L, et al.
Shortened Infant Telomere Length Is Associated with Attention Deficit/Hyperactivity Disorder Symptoms in Children at Age Two Years: A Birth Cohort Study..
Int J Mol Sci
23(9)
:
2022
view publication
Lucas, R, Dennington, P, Wood, E, Murray, KJ, Cheng, A, Burgner, D, Singh-Grewal, D.
Epidemiology of Kawasaki disease in Australia using two nationally complete datasets..
J Paediatr Child Health
58(4)
:
674 -682
2022
view publication
Tanner, S, Thomson, S, Drummond, K, O'Hely, M, Symeonides, C, Mansell, T, Saffery, R, Sly, PD, Collier, F, Burgner, D, et al.
A Pathway-Based Genetic Score for Oxidative Stress: An Indicator of Host Vulnerability to Phthalate-Associated Adverse Neurodevelopment..
Antioxidants (Basel)
11(4)
:
2022
view publication
Lycett, KM, Wijayawickrama, DJ, Liu, M, Grobler, A, Burgner, DP, Baur, LA, Liu, R, Lange, K, Wake, M, Kerr, JA.
Does an inflammatory diet affect mental well-being in late childhood and mid-life? A cross-sectional study..
Br J Nutr
127(6)
:
939 -947
2022
view publication
Carmona, EG, García-Giménez, JA, López-Mejías, R, Khor, CC, Lee, J-K, Taskiran, E, Ozen, S, Hocevar, A, Liu, L, Gorenjak, M, et al.
Identification of a shared genetic risk locus for Kawasaki disease and immunoglobulin A vasculitis by a cross-phenotype meta-analysis..
Rheumatology (Oxford)
61(3)
:
1204 -1210
2022
view publication